Home  >  Products  >  LYCAT (lysocardiolipin acyltransferase) Blocking Peptide (the middle region of protein) (100ug)
LYCAT (lysocardiolipin acyltransferase) Blocking Peptide (the middle region of protein) (100ug)

LYCAT (lysocardiolipin acyltransferase) Blocking Peptide (the middle region of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-LYCAT antibody (Catalogue #: ARP44426_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP44426
Size: 100 ug
Weight: 44kDa
Gene: 253558
Format: Lyophilized powder
Target: LYCAT is an acyl-CoA:lysocardiolipin acyltransferase. It possesses both lysophosphatidylinositol acyltransferase (LPIAT) and lysophosphatidylglycerol acyltransferase (LPGAT) activities. LYCAT recognizes both monolysocardiolipin and dilysocardiolipin as substrates with a preference for linoleoyl-CoA and oleoyl-CoA as acyl donors. LYCAT acts as a remodeling enzyme for cardiolipin, a major membrane polyglycerophospholipid. It converts lysophosphatidic acid (LPA) into phosphatidic acid (PA) with a relatively low activity. LYCAT is required for establishment of the hematopoietic and endothelial lineages.
Alternative names: ALCAT1; FLJ37965; UNQ1849
See Full Product Listings >